|
JPS60136511A
(ja)
|
1983-12-26 |
1985-07-20 |
Eisai Co Ltd |
高尿酸血症治療剤
|
|
EP0238554A4
(en)
|
1985-09-27 |
1987-10-27 |
Univ California |
SYSTEM FOR TRANSDERMAL DELIVERY OF MEDICAMENTS TO LIPOSOMES.
|
|
JPS6295134A
(ja)
|
1985-10-21 |
1987-05-01 |
Nippon Saafuakutanto Kogyo Kk |
リポソ−ムの製造法
|
|
US5015483A
(en)
|
1989-02-09 |
1991-05-14 |
Nabisco Brands, Inc. |
Liposome composition for the stabilization of oxidizable substances
|
|
US5498607A
(en)
|
1990-07-30 |
1996-03-12 |
University Of Miami |
Treatment for hypercholesterolemia
|
|
JP3765579B2
(ja)
|
1990-08-24 |
2006-04-12 |
イーデーエーアー アーゲー |
作用物質投与用超微小滴状調剤
|
|
US6165500A
(en)
|
1990-08-24 |
2000-12-26 |
Idea Ag |
Preparation for the application of agents in mini-droplets
|
|
US5498420A
(en)
|
1991-04-12 |
1996-03-12 |
Merz & Co. Gmbh & Co. |
Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions
|
|
JPH08509202A
(ja)
|
1992-07-08 |
1996-10-01 |
ディアノルム―ゲレーテ・ゲー・マイエルホファー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
リポソーム、それを調製する方法及び薬調製におけるその用途
|
|
FR2714382B1
(fr)
|
1993-12-27 |
1996-02-02 |
Roussel Uclaf |
Phospholipides vecteur de molécule active, leur préparation et leur utilisation dans des compositions cosmétiques ou dermatologiques.
|
|
DE4447287C1
(de)
|
1994-12-30 |
1996-11-07 |
Cevc Gregor |
Präparat zum Wirkstofftransport durch Barrieren
|
|
US5902604A
(en)
|
1995-06-06 |
1999-05-11 |
Board Of Regents, The University Of Texas System |
Submicron liposome suspensions obtained from preliposome lyophilizates
|
|
FR2767691B1
(fr)
|
1997-08-27 |
2000-02-18 |
Oreal |
Utilisation d'une dispersion a base de vehicules lipidiques comme composition anti-inflammatoire
|
|
SK284338B6
(sk)
*
|
1997-11-19 |
2005-02-04 |
Schering Aktiengesellschaft |
Kompozícia s kyselinou azelaínovou
|
|
US6165997A
(en)
|
1997-11-20 |
2000-12-26 |
Statens Serum Institut |
Phospholipids having antimicrobial activity with or without the presence of antimicrobials
|
|
CN1322129A
(zh)
|
1998-09-01 |
2001-11-14 |
伊迪亚股份公司 |
带电穿透剂通过屏障的电控转运
|
|
CZ20012038A3
(cs)
|
1998-12-23 |
2001-09-12 |
Idea Ag |
Zdokonalený přípravek pro topické, neinvazivní použití in vivo
|
|
EP1031346B1
(en)
|
1999-01-27 |
2002-05-02 |
Idea Ag |
Noninvasive vaccination through the skin
|
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
WO2001001962A1
(en)
|
1999-07-05 |
2001-01-11 |
Idea Ag. |
A method for the improvement of transport across adaptable semi-permeable barriers
|
|
US6248728B1
(en)
|
2000-03-10 |
2001-06-19 |
Kansas State University Research Foundation |
Phosphatidylcholine compositions and methods for lowering intestinal absorption and plasma levels of cholesterol
|
|
US6191121B1
(en)
*
|
2000-04-06 |
2001-02-20 |
Nicholas V. Perricone |
Treatment of skin damage using polyenylphosphatidylcholine
|
|
DK1272160T3
(da)
|
2000-04-12 |
2007-05-21 |
Liplasome Pharma As |
Lipidbaseret lægemiddelleveringssystem til topisk applikation
|
|
TWI281407B
(en)
|
2000-09-18 |
2007-05-21 |
Vasogen Ireland Ltd |
Apoptosis-mimicking synthetic entities and use thereof in medical treatment
|
|
WO2002062316A1
(de)
|
2001-02-08 |
2002-08-15 |
Vectron Therapeutics Ag |
Invasomen zur therapie von erkrankungen, ihre herstellung und verwendung
|
|
WO2002096435A2
(en)
|
2001-05-31 |
2002-12-05 |
Pharmacia Corporation |
Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol
|
|
JP2004535434A
(ja)
|
2001-06-25 |
2004-11-25 |
デピユイ |
関節炎にかかった関節の処置のためのグリコサミノグリカン類のリポソームカプセル化
|
|
CA2368656A1
(en)
|
2002-01-21 |
2003-07-21 |
Vasogen Ireland Limited |
Receptor-ligand pairing for anti-inflammatory response
|
|
AU2003233396B2
(en)
|
2002-03-13 |
2007-05-24 |
Thomas Skold |
Water-based delivery systems
|
|
US20040009180A1
(en)
|
2002-07-11 |
2004-01-15 |
Allergan, Inc. |
Transdermal botulinum toxin compositions
|
|
US7473432B2
(en)
|
2002-10-11 |
2009-01-06 |
Idea Ag |
NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
|
|
NZ538571A
(en)
|
2002-10-11 |
2007-05-31 |
Idea Ag |
Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
|
|
JP2004131432A
(ja)
|
2002-10-11 |
2004-04-30 |
Kumamoto Technology & Industry Foundation |
悪性腫瘍抑制剤
|
|
AU2004235781A1
(en)
|
2003-05-02 |
2004-11-18 |
Aronex Pharmaceuticals, Inc. |
Lipid platinum complexes and methods of use thereof
|
|
WO2005007169A2
(en)
|
2003-07-21 |
2005-01-27 |
Vasogen Ireland Limited |
Liposomes containing phosphate glycerol groups for treating acute inflammatory condition
|
|
JP2005179313A
(ja)
*
|
2003-12-24 |
2005-07-07 |
Shu Uemura:Kk |
皮膚化粧料用基剤の製造方法および皮膚化粧料
|
|
US7476432B2
(en)
|
2004-05-28 |
2009-01-13 |
Tecton Products |
Phosphorescent pultrusion
|
|
CA2584475A1
(en)
|
2004-11-12 |
2006-05-18 |
Idea Ag |
Extended surface aggregates in the treatment of skin conditions
|
|
WO2006086992A2
(en)
|
2005-02-18 |
2006-08-24 |
Liplasome Pharma A/S |
Drug delivery systems containing phqspholipase a2 degradable lipid prodrug derivatives and the therapeutic uses thereof as. e.g. wound healing agents and peroxisome proliferator activated receptor ligands
|
|
US20070042008A1
(en)
|
2005-08-18 |
2007-02-22 |
Bodybio, Inc. |
Compositions containing phosphatidylcholine and essential fatty acids
|
|
BRPI0615411A2
(pt)
|
2005-08-29 |
2012-12-04 |
Sepsicure L L C |
uso de um ácido da bìlis ou de um sal de ácido da bìlis e um fosfolipìdeo
|
|
EP1968567B1
(en)
|
2005-12-20 |
2014-06-18 |
Cenestra, Llc |
Omega 3 fatty acid formulations
|
|
JP5009547B2
(ja)
*
|
2006-03-31 |
2012-08-22 |
株式会社コーセー |
顔料とリポソームを含む化粧料
|
|
US7544375B1
(en)
|
2006-06-12 |
2009-06-09 |
Swiss Skin Repair, Inc. |
Composition
|
|
CA2664944C
(en)
|
2006-09-28 |
2016-06-14 |
Hadasit Medical Research Services & Development Limited |
Use of glycerophospholipids for joint lubrication
|
|
JP4732307B2
(ja)
|
2006-11-20 |
2011-07-27 |
株式会社アンズコーポレーション |
ナノエマルション及びそれを配合した化粧料
|
|
US20100130611A1
(en)
|
2006-12-20 |
2010-05-27 |
Cenestra Llc |
Omega 3 fatty acid formulations
|
|
EP1938801A1
(en)
|
2006-12-22 |
2008-07-02 |
Biofrontera Bioscience GmbH |
Nanoemulsion
|
|
US9511016B2
(en)
|
2007-06-12 |
2016-12-06 |
Epicentrx, Inc. |
Topical composition for treating pain
|
|
ITVR20080006A1
(it)
|
2008-01-23 |
2009-07-24 |
David Ceretta |
Apparato per la realizzazione di elementi d'impasto
|
|
ES2335636B1
(es)
|
2008-02-29 |
2011-05-11 |
Lipotec, S.A. |
Composicion cosmetica o dermofarmaceutica de micelas mixtas.
|
|
JP2009256331A
(ja)
|
2008-03-25 |
2009-11-05 |
Nagase Chemtex Corp |
高尿酸血症、又は痛風の予防、改善、又は治療剤
|
|
US20100105139A1
(en)
|
2008-10-27 |
2010-04-29 |
Remco Alexander Spanjaard |
Ligand Targeted Nanocapsules for the delivery of RNAi and other Agents
|
|
CA2751412A1
(en)
|
2009-02-05 |
2010-08-12 |
Targeted Delivery Technologies Limited |
Methods of reducing the proliferation and viability of microbial agents
|
|
JP2012528846A
(ja)
|
2009-06-03 |
2012-11-15 |
マヨ、ジョン、チャールズ |
深部組織の痛みを治療するための製剤
|
|
GB2486371A
(en)
|
2009-08-21 |
2012-06-13 |
Targeted Delivery Technologies Ltd |
Vesicular formulations
|
|
EP2382994A1
(en)
|
2010-04-26 |
2011-11-02 |
Maurizio Victor Cattaneo |
Ligand targeted nanocapsules for the delivery of RNAi and other agents
|
|
WO2011162802A1
(en)
|
2010-06-21 |
2011-12-29 |
Virun, Inc. |
Compositions containing non-polar compounds
|
|
US20120045405A1
(en)
|
2010-08-18 |
2012-02-23 |
Gilman Miles E |
Under eye cream
|
|
GB201206486D0
(en)
|
2012-04-12 |
2012-05-30 |
Sequessome Technology Holdings Ltd |
Vesicular formulations and uses thereof
|
|
GB201208409D0
(en)
|
2012-05-14 |
2012-06-27 |
Sequessome Technology Holdings Ltd |
Vesicular formulations, kits and uses
|
|
GB201208384D0
(en)
|
2012-05-14 |
2012-06-27 |
Sequessome Technology Holdings Ltd |
Vesicular formulations, uses and methods
|
|
SG11201600424VA
(en)
|
2013-07-31 |
2016-02-26 |
Sequessome Technology Holdings Ltd |
Vesicles
|